chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Administered the vaccine from a vial that was open on 01-Jun-2022 stored in the refrigerator on same day and administered on 27-Jul-2022; Administered the vaccine from a vial that was open on 01-Jun-2022 stored in the refrigerator on same day and administered on 27-Jul-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine from a vial that was open on 01-Jun-2022 stored in the refrigerator on same day and administered on 27-Jul-2022) and PRODUCT STORAGE ERROR (Administered the vaccine from a vial that was open on 01-Jun-2022 stored in the refrigerator on same day and administered on 27-Jul-2022) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046L21A) for COVID-19 prophylaxis.     It was unknown if the patient had medications, food and other products allergy. Medical history reported relating to mentioned AE and both Acute and Chronic illnesses at the time of vaccination was unknown. It was unknown if the patient had ever been diagnosed or tested positive for COVID-19. It was unknown whether any other vaccines were given within 1 month prior to Moderna COVID-19 vaccine.  Previously administered products included for Product used for unknown indication: Jhonson & Johson (First booster) on 28-Nov-2021, Jhonson & Johson (Primary series:2) and Jhonson & Johson (Primary series:1). Past adverse reactions to the above products included No adverse event with Jhonson & Johson, Jhonson & Johson and Jhonson & Johson.    On 27-Jul-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine from a vial that was open on 01-Jun-2022 stored in the refrigerator on same day and administered on 27-Jul-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Administered the vaccine from a vial that was open on 01-Jun-2022 stored in the refrigerator on same day and administered on 27-Jul-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine from a vial that was open on 01-Jun-2022 stored in the refrigerator on same day and administered on 27-Jul-2022) and PRODUCT STORAGE ERROR (Administered the vaccine from a vial that was open on 01-Jun-2022 stored in the refrigerator on same day and administered on 27-Jul-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  Patient received the second booster dose on 27-Jul-2022.  It was unknown whether adverse event cause patient to seek medical care. The patient did not experienced a similar event in the past. The vial did not undergo any temperature excursions.  No treatment information was reported.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 5 (booster), single (Batch/Lot number: unknown), in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Lupus (SLE)" (unspecified if ongoing). Concomitant medication(s) included: HYDROXYCHLOROQUINE. Past drug history included: Aspirin, reaction(s): "Known allergies: Aspirin". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.   Clinical information: Patient received anti-viral, Paxlovid as covid-19 treatment from 21Dec2022 to 26Dec2022.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Developed pharyngitis (which led to Pneumonia) on 22JUN90; Vaccinee was ill for 3 wks was treated w/antibiotics; Recovered;
Extreme arm pain-unable to move my arm. Slightest touch causes extreme sharp pain, pain radiated from injection site down to my hand and fingers  Fever, body aches, back ache, slight headache
Infected on May2022 with Omicron; Infected on May2022 with Omicron; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), in 2022 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose number unknown (booster), single (Batch/Lot number: unknown) and as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Lyme", start date: 2014, stop date: 2015, notes: bad Lyme successfully treated with Amoxicillin and Azithromycin for a year, followed by tinctures. The patient's concomitant medications were not reported. Past drug history included: Amoxicillin for Lyme, notes: bad Lyme successfully treated with Amoxicillin and Azithromycin for a year, followed by tinctures; Azithromycin for Lyme, notes: bad Lyme successfully treated with Amoxicillin and Azithromycin for a year, followed by tinctures. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset May2022, outcome "unknown", COVID-19 (medically significant) with onset May2022, outcome "recovered" and all described as "Infected on May2022 with Omicron". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (May2022) Positive, notes: Infected on May2022 with Omicron. Therapeutic measures were taken as a result of covid-19.  Clinical course: Offering to participate in trial of a 6-Valent OspA-Based Lyme Disease Vaccine (VLA15). The patient had bad Lyme in 2014-15; around 6 months after infection, a doctor successfully treated the patient with Amoxicillin and Azithromycin for a year, followed by tinctures. The patient never wanted to repeat that and would be happy to help develop the vaccine. The patient was 76, healthy, physically and professionally active. The patient was also a grateful recipient of Pfizer COVID vaccine, 4x boosted. Infected on May2022 with Omicron a month after 2nd booster: mild symptoms that vanished after beginning Paxlovid.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Had vaccine 7-12-07. On 7-19-07 after lunch pt stated itching and burning on right hip area. Looked and noticed that it was a rash. Pt was seen on 7-20-07 and given Valtrex 1gm take BID  x 8 days
Patient came into store and showed a raised lesion (she called it a boil) in the upper arm but NOT where the flu shot was administered  She said the warmth and discomfort radiated from the area of the flu administration site.
Within 8-10 hours: dull headache, fever of 100-101, severe aches, joint and muscle aches, lethargy, and severe left arm pain for about 24 hours from collarbone to wrist.
COVID vaccine breakthrough case. Patient vaccinated on 2/25/21 Moderna 024M20A, 3/25/21 Moderna 017B21A and boosted on 10/28/21 Moderna 939903 (lot number stated in system).
death certificate / cause of death / vaccine injury; passed out; shingles / it spread / 85% covered and on morphine / all over her body; constant pain / couldnt have clothes on at all / increasing pain / pain killed her; fell; breaking her arm; breaking / collsr bone; huge gash on her face; coukd barely move; was bed ridden; This case was reported by a consumer via interactive digital media and described the occurrence of injury in a elderly female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 3 weeks after receiving Shingles vaccine, the patient experienced injury (serious criteria death), passed out (serious criteria GSK medically significant), shingles, pain, fall, arm fracture, fractured collar bone, face injury, mobility decreased and bedridden. The patient was treated with morphine. On an unknown date, the outcome of the injury was fatal and the outcome of the passed out, shingles, fall, arm fracture, fractured collar bone, face injury, mobility decreased and bedridden were unknown and the outcome of the pain was not recovered/not resolved. The reported cause of death was injury.   The reporter considered the injury to be related to Shingles vaccine. It was unknown if the reporter considered the passed out, shingles, pain, fall, arm fracture, fractured collar bone, face injury, mobility decreased and bedridden to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The reporter was the patient's neighbor. The patient's doctor suggested to prevent shingles, but the patient got it. 3 weeks after receiving Shingle vaccine, the patient had shingles. The patient's doctor told her, it would last a week or 2weeks Instead of getting better, the shingles were spread. Within a month after receiving Shingles vaccine, the patient was 50 percent covered with shingles and in constant pain. Another month and the patient were 85 percent covered and she was on Morphine. After 3 months, the patient was in so much pain, she passed out and she fall, and her arm and collar bone were broken and making a huge gash on her face. After 6 months, the patient could barely move. After 9 months, the patient was bed ridden. After 13 months, shingles was all over her body and she couldn't have clothes on at all. After 22 months of constant and increasing pain, then the pain killed her. The patient's death certificate said cause of death was vaccine injury. It was reported that, the patient died a horrible suffering death due to a shingles vaccine. The patient's doctor no longer advised or given the shingles vaccine. He also no longer given other vaccines because after he researched every vaccine, he had given anyone and said what he learned shocked him, and he did not trust vaccines anymore. The reporter had 3 kids in family and had severe adverse reactions to vaccines. The reporter's one of grandsons was hospitalized for vaccine poisoning.; Reported Cause(s) of Death: Vaccine injury
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 54-year-old male patient received BNT162b2 (BNT162B2), on 02Apr2021 at 12:00 as dose 1, single (Lot number: ERE734), in left arm, on 24Apr2021 at 12:00 as dose 2, single (Lot number: EW0175), in left arm and on 12Dec2021 at 12:00 as dose 3 (booster), single (Lot number: 330308D) at the age of 54 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant) with onset 09May2022 at 12:00, outcome "unknown", COVID-19 (medically significant) with onset 09May2022 at 12:00, outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: 8 days after finishing 5 day Paxlovid course; Positive, notes: initially testing positive; Positive, notes: Still testing Covid positive 15 days after initially testing positive. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Additional Information: The patient did not receive other medication in 2weeks. Anti-viral details: COVID 19 Treatment, Treatment start date=03May2022 and stop date=08May2022. Adverse event: Still testing Covid positive 15 days after initially testing positive and 8 days after finishing 5-day Paxlovid course. Symptoms mild after Paxlovid course. Sore throat. Runny nose. Adverse event start date: 09May2022 at 12:00 AM. If patient is Recovering. If the patient was not received treatment. The patient had no known allergies. Other medical history None.  No follow-up attempts are possible. No further information is expected.
Mom called & c/o redness at inject site. Over 1-2 days leg swelled all around & would'nt move & then resolved gradually.
pt laid around a lot, fever off & on, lethargic since 3-4 days p/vax;low grade fever;hives off & on;lt jaw swelled 14SEP96;rt jaw swelled 15SEP96;can't eat or talk right;passed out & twitched;MD said mumps poss sz;gums swollen;
This case was reported by a contact and described the occurrence of injection site pain in a 50-year-old female patient who received SHINGRIX. The patient's past medical history included migraine headache. On 23rd February 2018, the patient received the 1st dose of SHINGRIX .5 ml. In February 2018, less than a week after receiving SHINGRIX, the patient experienced injection site pain. On an unknown date, the patient experienced migraine headache and floating feeling. The patient was treated with IMITREX, Steroid Pack (NOS) and TOPAMAX. On an unknown date, the outcome of the injection site pain was recovered/resolved and the outcome of the migraine headache was recovering/resolving and the outcome of the floating feeling was unknown. The reporter considered the injection site pain, migraine headache and floating feeling to be related to SHINGRIX. Additional details were provided as follows: The caller was patient who received SHINGRIX on left arm. The patient experienced arm pain at injection site that lasted for about one week after the dose was given. The caller reported that the 1 day after receiving the dose of SHINGRIX she experienced debilitating migraine headache for which she took IMITREX. This did not resolve and she went to her doctor and was prescribed TOPAMAX which also did not resolve and was later prescribed a steroid pack. The caller reported that the headaches had improved and she felt better but had not completely resolved as she still had slight feeling of floatiness in the area where she had the headache.
pruritis and rash small raised red beneath breasts under arms stomach and upper chest; pruritis and rash small raised red beneath breasts under arms stomach and upper chest; Booster; other vaccine same date product=Flu; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 65 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 03Nov2021 13:45 (Batch/Lot number: unknown) at the age of 65 years as dose 3 (booster), single for covid-19 immunisation; influenza vaccine (FLU), administered in arm right, administration date 03Nov2021 (Batch/Lot number: unknown) as single for immunisation. Relevant medical history included: "HTN" (unspecified if ongoing); "HDL" (unspecified if ongoing); "narcolepsy" (unspecified if ongoing). Concomitant medication(s) included: ADDERALL; TELMISARTAN; ROSUVASTATIN; PANTOPRAZOLE. Past drug history included: Dermabond, reaction(s): "Known Allergies: Dermabond". Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: Unknown. Same facility has information, Location of injection: Arm Left, Vaccine Administration Time: 01:00 PM), administration date: 11Jan2021, when the patient was 64 years old, for COVID-19 Immunisation; Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. Same facility has information, Location of injection: Arm Right, Vaccine Administration Time: 02:00 PM), administration date: 21Dec2020, when the patient was 64 years old, for COVID-19 Immunisation. The following information was reported: IMMUNISATION (non-serious) with onset 03Nov2021, outcome "unknown", described as "Booster"; PRODUCT USE ISSUE (non-serious) with onset 03Nov2021, outcome "unknown", described as "other vaccine same date product=Flu"; ERYTHEMA (non-serious), RASH PRURITIC (non-serious) all with onset 05Nov2021, outcome "recovering" and all described as "pruritis and rash small raised red beneath breasts under arms stomach and upper chest". Therapeutic measures were taken as a result of erythema, rash pruritic.  Additional information: The patient was treated with steroid ointment for pruritis and rash small raised red beneath breasts under arms stomach and upper chest. The patient did receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
severe intense itching starting on face, scalp, med to arms, back of hands to chest & back; sx above waist only; red rash, eczema, purpura, red patches of skin w/some patches raised;  oozing vesicular lesions, papules plaque; erythema multi
Vaccine was administered at 3:30 pm Friday, 6/12/2020.   I noted extreme fatigue and dizziness on Saturday morning 6/13.  My blood pressure was low for me at 85/70.  By 9 pm on Sat. 6/13, my lips started to swell.  I lips were significantly swollen by Sunday, 6/14, and the low blood pressure persisted.  When I awoke and stood up out of bed on Monday, 6/14, I fainted, hit my face into the window frame/wall.  I bruised my chin and upper lip and have sore upper teeth.
Patient 30 y/o Female, received her first dose of Pfizer COVID-19 vaccination (Lot #ER8729, exp. 07/31/21) on 4/3/21 around 11:10am. While in the post-vaccination observation area, notified EMTs around 11:15am that she felt lightheaded, sweaty, nauseous, dizzy, had ringing in her ears, fainting, and was experiencing "tunnel-vision." EMT and responded to . had a BP of 108/60 at 11:15am. Co-lead , RN attended to after being notified. Upon assessment, is arousable, alert and oriented x 4, verbally responsive but sluggish to respond. No signs or symptoms of respiratory distress. Medical history of asthma, phobia of needles, not currently taking any meds. 911 was called. 911 instructed  RN to not give any food or drink to . stated she was feeling a "little better" around 11:22am; appeared sweaty and reported mild dizziness and lightheadedness. At 11:25am, had a HR of 68 and a RR of 18 and O2 SAT OF 97%. At 11:28am reported mild lightheadedness; her symptoms of sweatiness and dizziness had resolved. At 11:30am the AMR Paramedics arrived, as well as the Fire Dept. refused to be taken by ambulance to the ER. Paramedics monitored at the site for the next 30 mins. in the post-vaccination observation area. Provided education to to notify next time during vaccination that she has a history of fainting from vaccinating. left the site on her own will; accompanied by her spouse, unassisted, no complaint of nausea, fatigue, and ambulates with steady gait. VAERS report submitted. Confirmation #
achy arm; achy shoulder; headache; neck pain; back pain; flu like symptoms; tired; achy; inappropriate schedule of vaccine; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 66-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in August 2018).   On 3rd June 2019, the patient received the 2nd dose of Shingrix. On 3rd June 2019, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On 4th June 2019, the patient experienced pain in arm, shoulder pain, headache, neck pain, back pain, influenza-like symptoms, tiredness and pain. On an unknown date, the outcome of the pain in arm, shoulder pain, headache, neck pain, back pain, influenza-like symptoms, tiredness and pain were not recovered/not resolved and the outcome of the drug dose administration interval too long was unknown.   It was unknown if the reporter considered the pain in arm, shoulder pain, headache, neck pain, back pain, influenza-like symptoms, tiredness, pain and drug dose administration interval too long to be related to Shingrix.  Additional details were provided as follows: The case was reported by the patient's wife. On the day of reporting, the patient woke up with achy arm, achy shoulder, headache, neck pain and back pain. The patient also experienced flu like symptoms, feeling tired and achy. This case had been linked with case US2019101070 (wife's case), reported by the same reporter.
No adverse event. Vaccine given after expiration date. no expiration date on vial or box.
Fever, headache, chills. Took Tylenol but little relief from symptoms.
10/06/2022 at 7:06 am PFIZER PEDI Orange Cap lot: FL2757. Expired vaccine administered. Expiration Date: 9/30/2022. 0.2 ml administered to patient
2/1/17 Father called and states patient received Typhoid vaccine 1/12/17 in Am. Since Friday night 1/13/17 he has been having a fever off and on. Treating with TYLENOL but still issue. 2/1/17 Am also Father states has not felt like eating sold food starting a few days after had Typhoid injection. Went to Urgent Care, but they could not find a reason for fever and symptoms. Fevers 99-100. 2/1/17 5 Pm has gone 7 hours with no fever now so father thinks better. Would usually have normal temp during day and then fever in evening or night. 2/3/17 Back to normal.
Client presented to clinic. Parent requested both pediatric Pfizer dose 1 and pediatric flu. Client received pediatric Pfizer dose 1 at first station, and was asked to move to the next station for pediatric flu dose. At next station client also received a second dose of Pediatric pfizer instead of pediatric flu. Client and parent notified. Client monitored for 30 minutes. No initial adverse reactions noted. Parent instructed to monitor child at home. Parent informed of follow up for next day - RN would call parent next day to check on client. No further concerns noted on follow up call. RN instructed parent that per guidelines, client may receive "second" dose in 21 days. Parent in agreement. Denies any further questions.
After the fever of 40C, chills, tiredness, nausea, headache. Started to feel pain on the left side of my face. Next day the pain has spread to my neck and ear. On day number three they felt numb, day number four lots of pain on my jaw. Day number 5 I couldn't even swallow and had difficulty breathing. When I looked in the mirror the left side of my face was very swollen like a ball and my face looked like it was paralyzed. I went to the ER where I was seen, but it remains the same days afterwards. My cheek doesn't look the same, looks bigger and the eye is droopy, my neck and ear hurts, it is difficult to swallow. My left arm is numb and swollen.
Injection of Typhoid vaccine given to high on shoulder and not in deltoid. Sparks or electricity and injection. Nerve? Pain in entire arm continued to worsen as night wore on. Sick all night and next day. Went to work and ended up going home because arm was so painful, nausea and major headache. Could hardly move arm. Pain has lessened but continues. Sporadic bursts of electricity, same pain during the days.
Redness/pain/swelling ecchymosis around injection site/area warm to touch. Dx: Allergic rx at doctor.
All mild Covid-19/flu like symptoms, in addition to sharp pain in armpit area, into the chest area, down the right side of upper body on side where vaccine was injected. Couldn't move right arm to should level or further without intense pain. Right armpit area swollen and extremely tender. Also experienced dizziness. This all began roughly eight hours after vaccine, lasting throughout the entire next day, and still in existence today.
Patient was given the Pfizer orange cap monovalent vaccine for a booster instead of the bivalent vaccine